Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis
Status:
Completed
Trial end date:
2017-08-26
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of the medical device "Excilor® Forte" in the treatment of
toenail onychomycosis. Half of the participants will receive the tested product and the other
half will receive a comparator (Amorolfin 5%). Patients will be followed during 6 months.